References
- Weinberg RA . Moving out: invasion and metastasis. In:The Biology of Cancer, Garland Sciences. Garland Science, Taylor & Francis Group, NY, USA, 641–722 (2013).
- Kalluri R , WeinbergRA. The basics of epithelial–mesenchymal transition. J. Clin. Invest.119 (6), 1420 (2009).
- Stafford LJ , VaidyaKS, WelchDR. Metastasis suppressors genes in cancer. Int. J. Biochem. Cell Biol.40 (5), 874–891 (2008).
- Fang BA , KovacevicZ, ParkKCet al.. Molecular functions of the iron-regulated metastasis suppressor, NDRG1, and its potential as a molecular target for cancer therapy. Biochim. Biophys. Acta.1845 (1), 1–19 (2014).
- Chen Z , ZhangD, YueF, ZhengM, KovacevicZ, RichardsonDR. The iron chelators Dp44mT and DFO inhibit TGF-β-induced epithelial–mesenchymal transition via up-regulation of N-Myc downstream-regulated gene 1 (NDRG1). J. Biol. Chem.287 (21), 17016–17028 (2012).
- Liu W , XingF, Iiizumi-GairaniMet al. N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis. EMBO Mol. Med.4 (2), 93–108 (2012).
- Lane DJ , SalettaF, RahmantoYS, KovacevicZ, RichardsonDR. N-myc downstream regulated 1 (NDRG1) is regulated by eukaryotic initiation factor 3a (eIF3a) during cellular stress caused by iron depletion. PloS ONE8 (2), e57273 (2013).
- Le NT , RichardsonDR. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood104 (9), 2967–2975 (2004).
- Bae D-H , JanssonPJ, HuangMLet al. The role of NDRG1 in the pathology and potential treatment of human cancers. J. Clin. Pathol.66 (11), 911–917 (2013).
- Kovacevic Z , ChikhaniS, LovejoyDB, RichardsonDR. Novel thiosemicarbazone iron chelators induce up-regulation and phosphorylation of the metastasis suppressor N-myc down-stream regulated gene 1: a new strategy for the treatment of pancreatic cancer. Mol. Pharmacol.80 (4), 598–609 (2011).
- Kovacevic Z , ChikhaniS, LuiGY, SivagurunathanS, RichardsonDR. The iron-regulated metastasis suppressor NDRG1 targets NEDD4L, PTEN, and SMAD4 and inhibits the PI3K and Ras signaling pathways. Antioxid. Redox Signal.18 (8), 874–887 (2013).
- Whitnall M , HowardJ, PonkaP, RichardsonDR. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl Acad. Sci. USA103 (40), 14901–14906 (2006).
- Van Roy F , BerxG. The cell–cell adhesion molecule E-cadherin. Cell. Mol. Life Sci.65 (23), 3756–3788 (2008).
- Heuberger J , BirchmeierW. Interplay of cadherin-mediated cell adhesion and canonical Wnt signaling. Cold Spring Harb. Perspect. Biol.2 (2), a002915 (2010).
- Zavadil J , BottingerEP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene24 (37), 5764–5774 (2005).
- Guan RJ , FordHL, FuY, LiY, ShawLM, PardeeAB. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer Res.60 (3), 749–755 (2000).
- Jin R , LiuW, MenezesSet al.. The metastasis suppressor, NDRG1, modulates β-catenin phosphorylation and nuclear translocation by mechanisms involving FRAT1 and PAK4. J. Cell Sci.127 (Pt 14), 3116–3130 (2014).
- Lovejoy DB , SharpDM, SeebacherNet al. Novel second-generation di-2-pyridylketone thiosemicarbazones show synergism with standard chemotherapeutics and demonstrate potent activity against lung cancer xenografts after oral and intravenous administration in vivo. J. Med. Chem.55 (16), 7230–7244 (2012).